The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Levodopa-induced psychosis: a kindling phenomenon
Abstract
Of 88 patients with idiopathic Parkinson's disease, without prior psychotic symptoms, and without significant dementia, nearly half had experienced vivid dreams, hallucinations, illusions, and nonconfusional as well as confusional psychoses as side effects of chronic levodopa therapy within the previous year of treatment. It was found that 61.3% of all hallucinations were associated with preexistent or concurrent vivid dream phenomena, that all psychotic states were associated with preexistent or concurrent vivid dreams and/or hallucinations, and that nonconfusional psychotic states tended to become confusional. These findings raise the possibility that chronic levodopa therapy may result in dopaminergic kindling and support the hypothesis that chronic dopaminergic agonism may, via such a kindling mechanism, play a role in the development of some types of psychoses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A permanent change in brain function resulting from daily electrical stimulation
Goddard, G. V., McIntyre, D. C., & Leech, C. K. (1969) · Experimental Neurology · doi:10.1016/0014-4886(69)90128-9 · Cited by 3,052
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Stevens, J. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200020023003 · Cited by 722
Psychiatric Aspects of Neurologic Disease
Plum, F. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500050064028 · Cited by 672
L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.
Barbeau, A. (1969) · PubMed · Cited by 410
Bloom, F. E., Costa, E., & Salmoiraghi, G. C. (1965) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27177-4 · Cited by 407
Victor, M. (1974) · Neurology · doi:10.1212/wnl.24.3.299 · Cited by 360
Amphetamines and Related Compounds
Burger, A. (1971) · Journal of Medicinal Chemistry · doi:10.1021/jm00283a900 · Cited by 344
Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system
Andén, N.-E., & Stock, G. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10025.x · Cited by 291
The action of dopamine on neurones of the caudate nucleus
McLennan, H., & York, D. H. (1967) · The Journal of Physiology · doi:10.1113/jphysiol.1967.sp008175 · Cited by 283
Klawans, H. L. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760240053004 · Cited by 220
Andén, N.-E., Dahlström, A., Fuxe, K., & Larsson, K. (1965) · Life Sciences · doi:10.1016/0024-3205(65)90076-7 · Cited by 179
Psychosis and Other Psychiatric Manifestations of Levodopa Therapy
Celesia, G. G., & Barr, A. N. (1970) · Archives of Neurology · doi:10.1001/archneur.1970.00480270003001 · Cited by 167
Levodopa‐Induced dopamine receptor hypersensitivity
Klawans, H. L., Goetz, C. G., Nausieda, P. A., & Weiner, W. J. (1977) · Annals of Neurology · doi:10.1002/ana.410020207 · Cited by 146
Das klinische Wirkungsbild von Clozapin: (Untersuchung mit dem AMP-System)
Angst, J., Bente, D., Berner, P., et al. (1971) · Pharmacopsychiatry · doi:10.1055/s-0028-1094313 · Cited by 133
The pharmacology of extrapyramidal movement disorders.
Klawans, H. L. (1973) · PubMed · Cited by 122
Mental symptoms in Parkinson's disease during chronic treatment with levodopa
Sweet, R. D., MCDOWELL, F. H., FEIGENSON, J. S., Loranger, A. W., & Goodell, H. (1976) · Neurology · doi:10.1212/wnl.26.4.305 · Cited by 119
Post, R. M., Kopanda, R. T., & Black, K. E. (1976) · PubMed · Cited by 118
Ascending Systems of Catecholamine Neurons from the Lower Brain Stem
Dahlström, A. B., Fuxé, K., Olson, L., & Ungerstedt, U. (1964) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1964.tb10446.x · Cited by 108
Does levodopa alter depression and psychopathology in Parkinsonism patients?
Marsh, G. G., & Markham, C. H. (1973) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.36.6.925 · Cited by 98
Effects of levodopa in parkinsonian patients with dementia
Sacks, O. W., Marjorie, B. C., Kohl, S., Messeloff, C. R., & Schwartz, W. F. (1972) · Neurology · doi:10.1212/wnl.22.5.516 · Cited by 78
Recent Advances in Parkinson’s Disease
Iams, J. F. (1972) · Physical Therapy · doi:10.1093/ptj/52.10.1117a · Cited by 75
Psychiatric aspects in Parkinsonism treated with L-dopa
Damásio, A. R., Lobo-Antunes, J., & Macedo, C. (1971) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.34.5.502 · Cited by 74
COCAINE, KINDLING, AND REVERSE TOLERANCE
Post, R. M., & Kopanda, R. T. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91342-2 · Cited by 63
Histochemical Localization at the Cellular Level of Hypothalamic Noradrenaline
Carlsson, A., FALCK, B., Hillarp, N., & Torp, A. (1962) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1962.tb02364.x · Cited by 61
Pathophysiology of schizophrenia and the striatum.
Klawans, H. L., Goetz, C., & Westheimer, R. K. (1972) · PubMed · Cited by 52
Klawans, H. L., Crossett, P., & Dana, N. (1975) · PubMed · Cited by 51
Klawans, H. L., Margolin, D. I., Dana, N., & Crosset, P. (1975) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(75)90151-3 · Cited by 41
Behavioral effects of l-dopa in man.
Fk, G. (1971) · PubMed · Cited by 33
The clinical use of levodopa in the treatment of Parkinson's disease.
MCDOWELL, F. H., Ch, M., Lee, J., Treciokas, L. J., & Ansel, R. (1971) · PubMed · Cited by 14
Cited by
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1978-06-01
- Volume
- 135
- Issue
- 6
- Pages
- 669-675
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W184247467
- Cited by
- 326
- References
- 30
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.